12944_2021_1589_MOESM3_ESM.tif (70.35 kB)
Download fileAdditional file 3 of Selective targeting of angiopoietin-like 3 (ANGPTL3) with vupanorsen for the treatment of patients with familial partial lipodystrophy (FPLD): results of a proof-of-concept study
figure
posted on 2021-12-06, 04:17 authored by Maria C. Foss-Freitas, Baris Akinci, Adam Neidert, Victoria J. Bartlett, Eunju Hurh, Ewa Karwatowska-Prokopczuk, Elif A. OralAdditional file 3.
Funding
akcea therapeutics
History
References
- 10.2147/DMSO.S206053
- 10.1210/jc.2018-02730
- 10.1007/s12020-019-01862-8
- 10.1016/j.metabol.2019.05.001
- 10.1210/jc.2016-2466
- 10.2337/dc18-0978
- 10.1210/jc.2011-1159
- 10.1038/nrendo.2017.119
- 10.1210/jc.2016-4043
- 10.1097/MOL.0000000000000679
- 10.1056/NEJMoa1612790
- 10.1097/MOL.0000000000000668
- 10.1194/jlr.P066183
- 10.1016/j.jacl.2017.06.013
- 10.1155/2019/6578327
- 10.1056/NEJMoa1701329
- 10.1007/BF00280883
- 10.2337/db16-1167
- 10.1038/srep11959
- 10.1148/radiol.13121360
- 10.2337/dc07-0025
- 10.1093/eurheartj/ehaa689
- 10.1210/jc.2014-1878
- 10.1007/s11892-018-1099-9
- 10.1016/j.metabol.2017.04.010
- 10.1002/hep.23116
- 10.1091/mbc.e15-10-0749
- 10.1111/nyas.13398
- 10.1155/2020/4242130
- 10.1053/j.gastro.2007.04.068
- 10.1002/oby.23049
- 10.1002/hep.25805
- 10.1007/s11892-018-1100-7
- 10.1210/jc.2018-02787
- 10.1210/jc.2014-4491
- 10.1016/j.jacl.2017.02.002
- 10.1089/nat.2018.0753
